机构:[1]Yu-Yue Pathology Scientific Research Center, Chongqing, 400039, China.[2]Jinfeng Laboratory, Chongqing, 401329, China.[3]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.四川省人民医院[4]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610042, China.四川省肿瘤医院[5]Cancer Center, Medical Research Institute, Southwest University, Chongqing, 400716, China.[6]Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.四川省人民医院[7]Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine & Guangxi Engineering Center in Biomedical Material for Tissue and Organ Regeneration & Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education, Guangxi Medical University, Nanning, 530021, China.[8]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.[9]Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine & Guangxi Engineering Center in Biomedical Material for Tissue and Organ Regeneration & Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education, Guangxi Medical University, Nanning, 530021, China. heming_liu@163.com.[10]Yu-Yue Pathology Scientific Research Center, Chongqing, 400039, China. xuchuan100@uestc.edu.cn.[11]Jinfeng Laboratory, Chongqing, 401329, China. xuchuan100@uestc.edu.cn.[12]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. xuchuan100@uestc.edu.cn.四川省人民医院[13]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China. xuchuan100@uestc.edu.cn.
第一作者机构:[1]Yu-Yue Pathology Scientific Research Center, Chongqing, 400039, China.[2]Jinfeng Laboratory, Chongqing, 401329, China.[3]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
推荐引用方式(GB/T 7714):
Hu Lanlin,Liu Mingxin,Tang Bo,et al.Correction: PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3[J].Cancer Gene Therapy.2024,doi:10.1038/s41417-024-00840-1.
APA:
Hu Lanlin,Liu Mingxin,Tang Bo,Li Xurui,Xu Huasheng...&Xu Chuan.(2024).Correction: PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3.Cancer Gene Therapy,,
MLA:
Hu Lanlin,et al."Correction: PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3".Cancer Gene Therapy .(2024)